Understanding Lung Cancer & Targeted Therapy | Dr. Siddharth Waman Turkar (Medical Oncologist)

Описание: What are the first signs of Lung Cancer that we often miss? How do modern treatments like Targeted Therapy differ from traditional Chemotherapy?

In this episode of our Cancer Awareness Series, we are joined by Dr. Siddharth Waman Turkar, a renowned Medical Oncologist at Apollo Hospital, Mumbai. Dr. Turkar brings his extensive experience to help us navigate the complexities of lung cancer, from early detection strategies to the latest advancements in personalized medicine.

Key highlights of this interview:

🔍 Early Red Flags: Identifying the subtle symptoms of Lung Cancer early on.

🏥 Screening & LDCT: Why Low-Dose CT scans are a game-changer for high-risk individuals.

💊 Precision Medicine: A deep dive into Targeted Therapy, Chemotherapy, and how they are used for Small Cell vs. Non-Small Cell Lung Cancer.

🇮🇳 Regional Challenges: Discussing the common delays in diagnosis seen in patients from North and West India.

💰 Financial Navigation: Insights into treatment costs, insurance, and available aid for comprehensive cancer care.

❤️ Message for Caregivers: One critical piece of advice for those supporting a patient through their recovery.

Watch this video to empower yourself with the right knowledge and learn about the resources available for lung cancer care in India.

Subscribe to stay updated with our expert-led cancer awareness series.

English Summary
Video Summary: Expert Insights on Lung Cancer with Dr. Siddharth Waman Turkar
In this episode, Dr. Siddharth Waman Turkar (Medical Oncologist, Apollo Hospital, Mumbai) explains the evolving landscape of lung cancer treatment. The discussion focuses on how "Precision Medicine" is allowing for more effective, personalized treatment plans with fewer side effects.

Key Discussion Points:
The Power of Early Detection: Dr. Turkar highlights that most lung cancers are detected late, and explains how regular screening for high-risk groups can dramatically improve survival rates.

The Medical Oncology Toolkit:

Targeted Therapy: How drugs are now designed to attack specific genetic mutations in cancer cells.

Chemotherapy: The role it still plays in modern treatment and what terms patients should know.

Biological Classification: Understanding why the distinction between Small Cell (SCLC) and Non-Small Cell Lung Cancer (NSCLC) is the foundation of every treatment strategy.

Access to Care: Addressing the practical barriers patients face, including diagnostic delays and navigating the costs of advanced treatment at multi-specialty hospitals like Apollo.

Holistic Support: Why emotional and practical support is just as important as the clinical treatment during the long journey of cancer recovery.

The Takeaway:
With the shift toward targeted and personalized therapies, the fight against lung cancer has become more strategic and effective. Knowledge of these options, combined with early screening, is the best defense a patient can have.